J&J sees AI halving the time to generate drug development leads
Summary
By Michael Erman NEW YORK, April 27 (Reuters) - Johnson & Johnson is using artificial intelligence to slash by half the time it takes to generate new leads for ...
Description
By Michael Erman NEW YORK, April 27 (Reuters) - Johnson & Johnson is using artificial intelligence to slash by half the time it takes to generate new leads for ...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source